Marker Therapeutics annual debt-to-equity ratio
2018
2019
2020
2021
2022
Marker Therapeutics Debt-to-Equity Ratio Growth & History (MRKR)
Marker Therapeutics's debt-to-equity ratio was 0.39 for fiscal 2022.
View full Marker Therapeutics company overviewMarker Therapeutics annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-12-31 | 0.39 | 0.12 | +43.64% |
| 2021 | 2021-12-31 | 0.27 | −0.18 | −39.64% |
| 2020 | 2020-12-31 | 0.45 | 0.44 | +3982.92% |
| 2019 | 2019-12-31 | 0.01 | 0.01 | — |
| 2018 | 2018-12-31 | 0.00 | — | — |
Marker Therapeutics quarterly debt-to-equity ratio
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2023 | 2023-03-31 | 0.47 | 0.14 | +43.37% |
| Q4 2022 | 2022-12-31 | 0.39 | 0.12 | +43.64% |
| Q3 2022 | 2022-09-30 | 0.34 | 0.11 | +48.59% |
| Q2 2022 | 2022-06-30 | 0.41 | 0.22 | +115.07% |
| Q1 2022 | 2022-03-31 | 0.33 | 0.16 | +95.16% |
| Q4 2021 | 2021-12-31 | 0.27 | −0.18 | −39.64% |
| Q3 2021 | 2021-09-30 | 0.23 | −0.17 | −42.50% |
| Q2 2021 | 2021-06-30 | 0.19 | −0.08 | −30.20% |
| Q1 2021 | 2021-03-31 | 0.17 | 0.16 | +1427.07% |
| Q4 2020 | 2020-12-31 | 0.45 | 0.44 | +3982.92% |
| Q3 2020 | 2020-09-30 | 0.40 | 0.39 | +3489.82% |
| Q2 2020 | 2020-06-30 | 0.27 | 0.26 | +2334.57% |
| Q1 2020 | 2020-03-31 | 0.01 | −0.00 | −8.58% |
| Q4 2019 | 2019-12-31 | 0.01 | 0.01 | — |
| Q3 2019 | 2019-09-30 | 0.01 | — | — |
| Q2 2019 | 2019-06-30 | 0.01 | — | — |
| Q1 2019 | 2019-03-31 | 0.01 | — | — |
| Q4 2018 | 2018-12-31 | 0.00 | — | — |
Marker Therapeutics debt-to-equity ratio trends
Between the periods ended 2018-12-31 and 2022-12-31, Marker Therapeutics's debt-to-equity ratio increased from 0.00 to 0.39, a change of 0.39. The latest reported quarter, Q1 2023, shows 0.47.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Marker Therapeutics source filings ↗